Cardiovascular disease (CVD) is the leading cause of death globally, with WHO estimates stating it represents 32% of deaths ...

Sheep were used by the team as the physiology of their hearts is similar to human hearts. When the animals had heart failure – induced by pace makers – which was sufficiently advanced to need ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines ...

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

The drug, from pharmaceutical company Eli Lilly and Co., was tested in the SUMMIT clinical trial at 146 sites in the United States and abroad. A total of 731 patients with diastolic heart failure ...

Using a gene-screening method they created, Stanford Medicine researchers may have discovered why an effective chemotherapy ...

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared ...

Drug discovery researchers have found that a natural fat molecule called 'lipoxin A4' (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.

Monash University drug discovery researchers have found that a natural fat molecule called "lipoxin A4" (LXA4) could ...

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and obesity, new research from UVA ...

The findings open the door to developing a new treatment for diabetes-induced heart disease. New research by Monash ...